Efficacy and Safety of Continuous Infusion of Terlipressin vs Bolus Terlipressin in ACLF Patients With Acute Esophageal Variceal Bleed
Clinical trial NCT06815770 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06815770
- Sponsor
- Institute of Liver and Biliary Sciences, India
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-10
- Primary completion
- 2026-02-28
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.